Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Telomir Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 101K | Feb 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TELO | Telomir Pharmaceuticals, Inc. | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | Chief Financial Officer |